These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34347332)

  • 1. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
    Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis.
    Vandergrift GW; Gill CG
    J Mass Spectrom; 2019 Sep; 54(9):729-737. PubMed ID: 31432563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S; Janssen RM; Olson K; Bridgeman J; Korol EE; Chu T; Ghafari C; Sabeti S; Buxton JA; Lysyshyn M
    Int J Drug Policy; 2022 Aug; 106():103741. PubMed ID: 35671687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in the unregulated opioid market in the context of extreme rates of overdose.
    Larnder A; Saatchi A; Borden SA; Moa B; Gill CG; Wallace B; Hore D
    Drug Alcohol Depend; 2022 Jun; 235():109427. PubMed ID: 35405459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond a spec: assessing heterogeneity in the unregulated opioid supply.
    Gozdzialski L; Louw R; Kielty C; Margolese A; Poarch E; Sherman M; Cameron F; Gill C; Wallace B; Hore D
    Harm Reduct J; 2024 Mar; 21(1):63. PubMed ID: 38491435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia.
    Mema SC; Sage C; Popoff S; Bridgeman J; Taylor D; Corneil T
    Harm Reduct J; 2018 Apr; 15(1):19. PubMed ID: 29625621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative assessment of key considerations for drug checking service implementation.
    Grace Rose C; Pickard AS; Kulbokas V; Hoferka S; Friedman K; Epstein J; Lee TA
    Harm Reduct J; 2023 Oct; 20(1):151. PubMed ID: 37848875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies.
    Crepeault H; Socias ME; Tobias S; Lysyshyn M; Custance A; Shapiro A; Ti L
    Drug Alcohol Rev; 2023 Mar; 42(3):538-543. PubMed ID: 36423900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019-April 2020.
    Scarfone KM; Maghsoudi N; McDonald K; Stefan C; Beriault DR; Wong E; Evert M; Hopkins S; Leslie P; Watson TM; Werb D;
    Harm Reduct J; 2022 Jan; 19(1):3. PubMed ID: 35012557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study.
    Tobias S; Ferguson M; Palis H; Burmeister C; McDougall J; Liu L; Graham B; Ti L; Buxton JA
    Int J Drug Policy; 2024 Jan; 123():104290. PubMed ID: 38101275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking.
    Gozdzialski L; Rowley A; Borden SA; Saatchi A; Gill CG; Wallace B; Hore DK
    Int J Drug Policy; 2022 Apr; 102():103611. PubMed ID: 35151084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada.
    Kennedy MC; Dong H; Tobias S; Buxton JA; Lysyshyn M; Tupper KW; Ti L
    Am J Prev Med; 2024 Jan; 66(1):10-17. PubMed ID: 37633426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
    Baldwin N; Gray R; Goel A; Wood E; Buxton JA; Rieb LM
    Drug Alcohol Depend; 2018 Apr; 185():322-327. PubMed ID: 29486421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
    Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portable gas chromatography-mass spectrometry in drug checking: Detection of carfentanil and etizolam in expected opioid samples.
    Gozdzialski L; Aasen J; Larnder A; Ramsay M; Borden SA; Saatchi A; Gill CG; Wallace B; Hore DK
    Int J Drug Policy; 2021 Nov; 97():103409. PubMed ID: 34392112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
    Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
    Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.